Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design

被引:13
|
作者
Rekka, Eleni A. [1 ]
Kourounakis, Panos N. [1 ]
Pantelidou, Maria [2 ]
机构
[1] Aristotelian Univ Thessaloniki, Dept Pharmaceut Chem, Sch Pharm, Thessaloniki 54124, Greece
[2] Frederick Univ, Sch Hlth Sci, Dept Pharm, CY-1036 Nicosia, Cyprus
关键词
Xenobiotic metabolism phase I II III; Cytochrome P450; Drug interactions; Drug design; Drug metabolising enzyme induction inhibition; Drug metabolism and pathologic conditions; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; LIVER MICROSOMAL CYTOCHROME-P-450; ADJUVANT-INDUCED ARTHRITIS; NITRIC-OXIDE SYNTHASE; PREGNANE X RECEPTOR; OXIDATIVE STRESS; RAT-LIVER; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; HEME OXYGENASE-1;
D O I
10.2174/1568026619666190129122727
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The biotransformation of xenobiotics is a homeostatic defensive response of the body against bioactive invaders. Xenobiotic metabolizing enzymes, important for the metabolism, elimination and detoxification of exogenous agents, are found in most tissues and organs and are distinguished into phase I and phase II enzymes, as well as phase III transporters. The cytochrome P450 superfamily of enzymes plays a major role in the biotransformation of most xenobiotics as well as in the metabolism of important endogenous substrates such as steroids and fatty acids. The activity and the potential toxicity of numerous drugs are strongly influenced by their biotransformation, mainly accomplished by the cytochrome P450 enzymes, one of the most versatile enzyme systems. Objective: In this review, considering the importance of drug metabolising enzymes in health and disease, some of our previous research results are presented, which, combined with newer findings, may assist in the elucidation of xenobiotic metabolism and in the development of more efficient drugs. Conclusion: Study of drug metabolism is of major importance for the development of drugs and provides insight into the control of human health. This review is an effort towards this direction and may find useful applications in related medical interventions or help in the development of more efficient drugs.
引用
收藏
页码:276 / 291
页数:16
相关论文
共 50 条
  • [21] Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans
    Fuhr, U
    CLINICAL PHARMACOKINETICS, 2000, 38 (06) : 493 - 504
  • [22] The impact of cytochrome P450 polymorphisms on expression of drug-metabolising enzymes in lymphocytes
    Owen, Andrew
    Cook, Clare
    Liptrott, Neill
    Martin, Phillip
    Harris, Richard
    Khoo, Saye H.
    Back, David J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 94 - 95
  • [23] An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment
    Ekhart, Corine
    Rodenhuis, Sjoerd
    Smits, Paul H. M.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    CANCER TREATMENT REVIEWS, 2009, 35 (01) : 18 - 31
  • [24] Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro
    Weiss, Johanna
    Haefeli, Walter Emil
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (05) : 484 - 487
  • [25] Exploring the role of drug-metabolising enzymes in antidepressant side effects
    Hodgson, Karen
    Tansey, Katherine E.
    Uher, Rudolf
    Dernovsek, Mojca Zvezdana
    Mors, Ole
    Hauser, Joanna
    Souery, Daniel
    Maier, Wolfgang
    Henigsberg, Neven
    Rietschel, Marcella
    Placentino, Anna
    Craig, Ian W.
    Aitchison, Katherine J.
    Farmer, Anne E.
    Dobson, Richard J. B.
    McGuffin, Peter
    PSYCHOPHARMACOLOGY, 2015, 232 (14) : 2609 - 2617
  • [26] Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes
    Wang, HB
    LeCluyse, EL
    CLINICAL PHARMACOKINETICS, 2003, 42 (15) : 1331 - 1357
  • [27] Glutathione depletion and anaesthesia in mice alter heme and drug metabolising enzymes
    Buzaleh, AM
    Batlle, AMD
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1723 (1-3): : 128 - 134
  • [28] The impact of the gut microbiota on hepatic drug-metabolising enzymes: Potential implications for clinical practise of neurogastroenterology
    Walsh, J.
    van de Wouw, M.
    Moloney, G.
    Cryan, J.
    Dinan, T.
    Griffin, B.
    Hyland, N.
    Clarke, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [29] Exploring the role of drug-metabolising enzymes in antidepressant side effects
    Karen Hodgson
    Katherine E. Tansey
    Rudolf Uher
    Mojca Zvezdana Dernovšek
    Ole Mors
    Joanna Hauser
    Daniel Souery
    Wolfgang Maier
    Neven Henigsberg
    Marcella Rietschel
    Anna Placentino
    Ian W. Craig
    Katherine J. Aitchison
    Anne E. Farmer
    Richard J. B. Dobson
    Peter McGuffin
    Psychopharmacology, 2015, 232 : 2609 - 2617
  • [30] Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
    Hongbing Wang
    Edward L. LeCluyse
    Clinical Pharmacokinetics, 2003, 42 : 1331 - 1357